Zeyuan Lu
Shanghai, 200233, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Advances in the pathogenesis and prevention of contrast-induced nephropathy.
Journal: Life sciences
Published: June 04, 2020
IL-17C has a pathogenic role in kidney ischemia/reperfusion injury.
Journal: Kidney international
Published: August 07, 2019
Long Noncoding RNA: Genomics and Relevance to Physiology.
Journal: Comprehensive Physiology
Published: June 13, 2019
Antithrombin III Attenuates AKI Following Acute Severe Pancreatitis.
Journal: Shock (Augusta, Ga.)
Published: July 19, 2017
Antithrombin Ⅲ is a Novel Predictor for Contrast Induced Nephropathy After Coronary Angiography.
Journal: Kidney & blood pressure research
Published: May 01, 2017
Antithrombin III prevents progression of chronic kidney disease following experimental ischaemic-reperfusion injury.
Journal: Journal of cellular and molecular medicine
Published: April 30, 2017
Underestimated incidence of kidney disease in nonrenal outpatient.
Journal: Renal failure
Published: January 26, 2017
Epigenetic Regulations in Diabetic Nephropathy.
Journal: Journal of diabetes research
Published: December 01, 2016
Sulodexide pretreatment attenuates renal ischemia-reperfusion injury in rats.
Journal: Oncotarget
Published: November 08, 2016
Sulodexide Protects Contrast-Induced Nephropathy in Sprague-Dawley Rats.
Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Published: October 25, 2016
SerpinC1/Antithrombin III in kidney-related diseases.
Journal: Clinical science (London, England : 1979)
Published: August 23, 2016
Last Updated: 09/26/2026